Reactions 1680, p190 - 2 Dec 2017 Autoimmune hypophysitis and hypoadrenocorticism: case report A 57-year-old woman developed autoimmune hypophysitis and hypoadrenocorticism following treatment with ipilimumab and nivolumab [routes not stated; not all time to reactions onsets stated]. The woman presented to the hospital with multiple metastatic melanoma lesions in the gastric wall, which were identified with endoscopy. She had a history of right uveal melanoma. At the first presentation, a CT scan demonstrated multiple metastatic lesions in the lungs and peritoneum. She was initiated on nivolumab 2 mg/kg per dose once every 3 weeks. However, another CT scan revealed progressive disease after six doses. Hence, four weeks after the last dose of nivolumab, she was initiated on ipilimumab 3 mg/kg per dose once every 3 weeks. She complained of fatigue, fever, muscle weakness and loss of appetite after two doses of nivolumab. Blood tests and head MRI revealed hypoadrenocorticism due to hypophysitis; assessed as treatment-related. The woman’s treatment with ipilimumab was discontinued and she received treatment with hydrocortisone. Subsequently, her symptoms improved. A month after the onset of hypoadrenocorticism, head MRI revealed no evidence of hypophysitis. Her hypoadrenocorticism was also successfully controlled by the hydrocortisone. Author comment: "At this point, blood tests and magnetic resonance imaging (MRI) of the head detected hypoadrenocorticism due to hypophysitis, which was assessed as being treatment-related." Ohnuma T, et al. Case of metastatic uveal melanoma in which an antitumor effect appeared after ipilimumab discontinuation due to autoimmune hypophysitis. Journal of Dermatology 44: 1325-1326, No. 11, Nov 2017. Available from: URL: http://doi.org/10.1111/1346-8138.13692 - Japan 803285511 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera